Cytokines such as interleukin-1beta (IL-1beta) stimulate inducible nitric oxide synthase (iNOS) expression and nitric oxide overproduction leading to beta-cell damage. Meanwhile, glucagon-like peptide-1 (GLP-1) and its potent analog exendin-4 (EX-4) were well known for beta-cell proliferation. However, the protective mechanisms of GLP-1 in beta-cells exposed to cytokines were not fully elucidated. Therefore, the effects of EX-4 on the IL-1beta-induced iNOS gene expression were investigated employing RINm5F beta-cells. EX-4 inhibited IL-1beta-induced iNOS protein expression and nitrite production. However, northern blot and promoter analyses showed that EX-4 failed to inhibit IL-1beta-induced iNOS mRNA expression and iNOS promoter activity. By electrophoretic mobility shift assay (EMSA), EX-4 did not alter the binding activity of NF-kappaB to the iNOS promoter. Consistent with the EMSA result, EX-4 did not inhibit nuclear translocation of p65. We also tested the effect of EX-4 on iNOS mRNA stability. Actinomycin D chase experiments showed that EX-4 did not affect the decay rate of iNOS mRNA and the promoter assay using the construct containing 3'-untranslated region of iNOS showed that EX-4 did not alter the stability of iNOS mRNA. Meanwhile, forskolin significantly inhibited IL-1beta-induced iNOS protein, which was reversed by H-89, a protein kinase A (PKA) inhibitor. Moreover, EX-4 pretreatment restored IL-1beta-induced decrease in cAMP toward control level. Additionally, the cycloheximide chase study demonstrated that EX-4 significantly accelerated iNOS protein degradation. We therefore concluded that EX-4 inhibited IL-1beta-induced iNOS protein and nitrite production via cAMP/PKA system irrespective of both transcriptional and posttranscriptional mechanisms of iNOS gene, and this inhibitory effect of EX-4 appears to be regulated at posttranslational level.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1677/JOE-08-0507 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Wedelolactone alleviates inflammation and cartilage degeneration by suppressing the NF-κB signaling pathway in osteoarthritis.
Int Immunopharmacol
December 2024
Department of Physiology, School of Basic Medical Sciences, Southwest Medical University, Luzhou, Sichuan 646099, China. Electronic address:
Article Synopsis
- Inflammation and ECM degradation are critical factors in the development of osteoarthritis (OA), and the study explores the protective role of Wedelolactone, a natural compound derived from medicinal plants.
- Pretreatment with Wedelolactone suppresses key inflammatory markers (like COX-2 and TNF-α) and enhances ECM-related proteins (like Collagen II) in chondrocytes, indicating its potential to protect against OA.
- The study reveals that Wedelolactone inhibits the NF-κB signaling pathway, which is central to inflammation in OA, and shows promise in relieving cartilage damage in animal models, suggesting its therapeutic potential for OA treatment.
mTORC2 inhibition by JR-AB2-011 improves IL-1β-induced inflammation, catabolic response, and apoptosis in human chondrocytes through IκB-α/NF-κB p65.
Cell Mol Biol (Noisy-le-grand)
October 2024
Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Turkey.
Article Synopsis
- * The study investigates how mTORC2 influences inflammatory responses in human chondrocytes, focusing on the Akt and NF-κB signaling pathways when treated with IL-1β.
- * Key findings indicate that inhibiting mTORC2 with JR-AB2-011 can block inflammation and cell death caused by IL-1β, suggesting it may be a promising therapeutic target for OA.
Evaluation of Anti-Inflammatory Activity of the New Cardiotonic Steroid γ-Benzylidene Digoxin 8 (BD-8) in Mice.
Cells
September 2024
Laboratory of Immunobiotechnology, Biotechnology Center, Federal University of Paraiba, João Pessoa 58.051-900, PB, Brazil.
Cardiotonic steroids are known to bind to Na+/K+-ATPase and regulate several biological processes, including the immune response. The synthetic cardiotonic steroid γ-Benzylidene Digoxin 8 (BD-8) is emerging as a promising immunomodulatory molecule, although it has remained largely unexplored. Therefore, we tested the immunomodulatory potential of BD-8 both in vitro and in vivo.
View Article and Find Full Text PDFNuciferine ameliorates osteoarthritis: An in vitro and in vivo study.
Int Immunopharmacol
December 2024
Department of Orthopaedic Surgery, The Third Hospital Affiliated to Wenzhou Medical University, Rui'an 325200, China; Zhejiang Provincial Key Laboratory of Orthopaedics, Wenzhou, China. Electronic address:
Osteoarthritis (OA) is the most common musculoskeletal disease and a leading cause of pain and disability. A key hallmark of OA is cartilage degradation, which occurs due to an imbalance between the synthesis and degradation of the extracellular matrix (ECM). Interleukin-1β(IL-1β) has been reported to regulate ECM metabolism.
View Article and Find Full Text PDFMulberroside A mitigates intervertebral disc degeneration by inhibiting MAPK and modulating Ppar-γ/NF-κB pathways.
J Inflamm (Lond)
August 2024
Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Background: Intervertebral disc degeneration (IVDD) is a common spine disease with inflammation as its main pathogenesis. Mulberroside A (MA), isolated from herbal medicine, possesses anti-inflammatory characteristics in many diseases. Whereas, there is little exploration of the therapeutic potential of MA on IVDD.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!